Chronic Myeloid Leukemia Coverage from Every Angle

François-Xavier Mahon, MD, PhD, on Using Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Posted: Monday, June 10, 2019

What are the criteria for halting treatment with tyrosine kinase inhibitors in patients with CML?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.